Corcept Therapeutics, Inc. (CORT)
34.64
-0.09
(-0.26%)
USD |
NASDAQ |
Jan 20, 15:09
Corcept Therapeutics Profit Margin (Quarterly): 9.32% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -27.62% |
| Johnson & Johnson | 21.47% |
| United Therapeutics Corp. | 42.36% |
| Ultragenyx Pharmaceutical, Inc. | -112.8% |
| Amicus Therapeutics, Inc. | 10.24% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.00% |
| Return on Assets | 12.77% |
| Return on Invested Capital | 15.84% |
| Gross Profit Margin (Quarterly) | 97.79% |
| Operating Margin (Quarterly) | 4.92% |
| Return on Net Operating Assets | 112.8% |